Laura MacConaill, PhD presents the cumulative body of work at the Dana Farber Cancer Institute and Brigham and Women’s Hospital during the conference at the Association for Molecular Pathology, November 2010.
View the online presentation to learn:
- Why targeting cancer based on genetics is crucial
- New genomic technologies that can aide in discovery vs. diagnosticanalysis
- About OncoMap for accelerated somatic mutation profiling
- A vision for personalized cancer medicine now and in the future